MyJournals Home  

RSS FeedsPharmaceuticals, Vol. 11, Pages 46: The Effects of Dabigatran and Rivaroxaban on Markers of Polymorphonuclear Leukocyte Activation (Pharmaceuticals)

 
 

17 may 2018 00:00:18

 
Pharmaceuticals, Vol. 11, Pages 46: The Effects of Dabigatran and Rivaroxaban on Markers of Polymorphonuclear Leukocyte Activation (Pharmaceuticals)
 




Dabigatran is an oral direct thrombin inhibitor, and rivaroxaban, a factor Xa inhibitor. Dabigatran has been implicated in the etiology of acute coronary syndromes and as these occur following inflammatory changes in the endothelium, we investigated the inflammatory potential of these agents in vitro. In order to do so, polymorphonuclear leukocytes (PMNL) were isolated from heparinized venous blood from non-smoking, healthy adults and exposed to dabigatran or rivaroxaban (0.5-10 ÁM). Generation of reactive oxygen species (ROS), elastase release, cytosolic Ca2+ fluxes, neutrophil extracellular trap (NET) formation and cell viability were measured using chemiluminescence, spectrophotometric and flow cytometric procedures respectively. However, with the exception of modest inhibitory effects on elastase release, neither agent at concentrations of up to 10 ÁM affected these markers of PMNL activation. Although no pro-inflammatory effects of dabigatran nor any difference between the two test agents were detected in vitro, the existence of a pro-inflammatory mechanism involving the generation of thrombin during dabigatran therapy cannot be fully excluded.


Del.icio.us Digg Facebook Google StumbleUpon Twitter
 
37 viewsCategory: Medicine, Pharmacology
 
Pharmaceuticals, Vol. 11, Pages 43: Evaluation of Anti-Toxoplasma gondii Effect of Ursolic Acid as a Novel Toxoplasmosis Inhibitor (Pharmaceuticals)
Pharmaceuticals, Vol. 11, Pages 45: Novel N4-Like Bacteriophages of Pectobacterium atrosepticum (Pharmaceuticals)
 
 
blog comments powered by Disqus


MyJournals.org
The latest issues of all your favorite science journals on one page

Username:
Password:

Register | Retrieve

Search:

Pharmacology

Use these buttons to bookmark us:
Del.icio.us Digg Facebook Google StumbleUpon Twitter


Valid HTML 4.01 Transitional
Copyright © 2008 - 2018 Indigonet Services B.V.. Contact: Tim Hulsen. Read here our privacy notice.
Other websites of Indigonet Services B.V.: Nieuws Vacatures News Tweets Travel Photos Nachrichten Indigonet Finances Leer Mandarijn